US Relapsing Remitting Multiple Sclerosis Market Segmentation
US Relapsing Remitting Multiple Sclerosis Market By Treatment (USD Million, 2025-2035)
- Immunomodulating Drugs
- Nrf2 Activators
- Interferons
- Others
US Relapsing Remitting Multiple Sclerosis Market By Route of Administration (USD Million, 2025-2035)
- Oral
- Intravenous
US Relapsing Remitting Multiple Sclerosis Market By End User (USD Million, 2025-2035)
- Hospitals
- Clinics
- Others